China Universal Asset Management Co., Ltd. Kiniksa Pharmaceuticals, Ltd. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 7,708 shares of KNSA stock, worth $149,226. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,708
Previous 7,708
-0.0%
Holding current value
$149,226
Previous $152,000
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding KNSA
# of Institutions
164Shares Held
40.6MCall Options Held
186KPut Options Held
157K-
Black Rock Inc. New York, NY4.19MShares$81.2 Million0.0% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.2MShares$62 Million10.07% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E93.14MShares$60.7 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.98MShares$57.7 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.81MShares$54.4 Million0.7% of portfolio
About Kiniksa Pharmaceuticals, Ltd.
- Ticker KNSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,470,400
- Market Cap $667M
- Description
- Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...